Company: MIRM
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001759425-25-000003
Chunk: 1

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-01-13
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure.

On January 13, 2025, in connection with its participation in the J. P. Morgan Healthcare Conference, the Company posted a corporate slide presentation in the “ Investors” portion of its website at www. mirumpharma. com. A copy of the presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.2.

The information in this Current Report on Form 8-K, including Exhibit 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.